Special Investigation - Efficacy/Safety Evaluation of Clarithromycin in Patients With Mycoplasma pneumoniae Pulmonary Infections
- Conditions
- Pulmonary Infections
- Registration Number
- JPRN-UMIN000011964
- Lead Sponsor
- Shigeru KOHNO
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Not provided
(1) Patients enrolled in entry of the study (2) Patients within 7days of CAM treatment (3) Patient who has condition in an improvement tendency by medication of other antimicrobial drugs (4) Patients whose diseases have taboo against the used antibiotics. (5) Patient with the patient or the past which has a chronic respiratory disease (6) Patient who has cough owing to foreign-body aspiration (7) Patient who has cough owing to gastroesophageal regurgitation (8) Patient who takes a medicine in an ACE inhibitor and has cough owing to it (9) Patient who has cough owing to it, cough asthma, atopic, the patient that has cough owing to allergic rhinitis (10) Patient who has cough owing to cardiac disease (11) Confirmed influenza virus infection. (12) Patient permitted the unusual shades, such as tuberculosis and a tumor, by the breast image inspection
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of adverse event, Rate of bacterial eradication
- Secondary Outcome Measures
Name Time Method